CDEK
← All organizations

C3J Therapeutics

For profitWebsite ↗

Also known as: C3 Jian, LLC

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Feb 1, 2014

Last known activity

Jun 28, 2017

Acquired by AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation → C3J Therapeutics → AmpliPhi Biosciences Corporation on May 1, 2019

Timeline

2000s

  1. Jun 1, 2005

    C3J Therapeutics— Founded

2010s

  1. May 1, 2019

    AmpliPhi Biosciences Corporation— Acquired By

  2. May 1, 2019

    AmpliPhi Biosciences Corporation— Now

  3. May 12, 2019

    AmpliPhi Biosciences Corporation— Acquired

Drugs by trial phase (7 distinct, 16 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (0 own, 4 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Other trials (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (7)

Details

Founded
Inglewood, CA, US Jun 1, 2005
Last known activity
Jun 28, 2017